1
|
Pontarelli A, Marchese V, Scolari C, Capone S, El-Hamad I, Donato F, Moioli R, Girardi E, Cirillo DM, Castelli F, Matteelli A. Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis. Travel Med Infect Dis 2018; 27:39-45. [PMID: 30347248 DOI: 10.1016/j.tmaid.2018.10.015] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2018] [Revised: 10/14/2018] [Accepted: 10/16/2018] [Indexed: 12/01/2022]
Abstract
BACKGROUND The World Health Organization conditionally recommends systematic screening of tuberculosis (TB) and Latent Tuberculosis Infection (LTBI) among asylum seekers (AS) from high-burden countries, but the effectiveness of different screening approaches is controversial. METHODS We report the results of a retrospective cohort analysis of TB and LTBI screening among consecutive AS in Brescia, Italy during 2015-2016. TB screening was based on symptoms, LTBI screening on the tuberculin skin test (TST). Logistic regression analysis was performed to identify factors associated with screening uptake. RESULTS Of 2904 registered AS 2567 (88.4%) were evaluated for TB, 62 (2.4%) had symptoms and active TB yield was 155/100,000. Prevalence and incidence TB rates were 545/100,000 persons and 220/100,000 person-years. Questionnaire screening identified 28.6% (4/14) prevalent cases. Of 2303 (89.7%) AS with TST result, the positivity rate was 36.6% (843/2303). Of the 843 candidates for LTBI treatment 413 (49.0%) completed the screening. LTBI treatment was prescribed to 190 (47.9%) of 397 eligible individuals, 10.8% (91) completed treatment. CONCLUSIONS TB prevalence and incidence rates were high in this AS population, but symptom-based screening performed poorly. LTBI cascade losses were significant and mainly attributable to the defragmentation of the health care system.
Collapse
Affiliation(s)
- Agostina Pontarelli
- University Department of Infectious and Tropical Diseases & WHO Collaborating Centre for TB/HIV and TB Elimination, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
| | - Valentina Marchese
- University Department of Infectious and Tropical Diseases & WHO Collaborating Centre for TB/HIV and TB Elimination, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy; Centre for Tropical Diseases, Sacro Cuore Don Calabria Hospital, Via Sempreboni 5, 37024, Negrar, Italy.
| | - Carla Scolari
- Unità Distretto Territoriale, ASST Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
| | - Susanna Capone
- Unità Distretto Territoriale, ASST Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
| | - Issa El-Hamad
- University Department of Infectious and Tropical Diseases & WHO Collaborating Centre for TB/HIV and TB Elimination, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy; Unità Distretto Territoriale, ASST Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
| | - Francesco Donato
- Unit of Hygiene, Epidemiology and Public Health, University of Brescia, Viale Europa 11, 25123, Brescia, Italy.
| | - Rolando Moioli
- Centro Pneumologico Preventivo, ASST Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
| | - Enrico Girardi
- Clinical Epidemiology Unit, Lazzaro Spallanzani National Institute for Infectious Diseases, Via Portuense, 292, 00149, Rome, Italy.
| | - Daniela Maria Cirillo
- IRCCS San Raffaele Scientific Institute, Via Olgettina Milano, 60, 20132, Milan, Italy.
| | - Francesco Castelli
- University Department of Infectious and Tropical Diseases & WHO Collaborating Centre for TB/HIV and TB Elimination, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
| | - Alberto Matteelli
- University Department of Infectious and Tropical Diseases & WHO Collaborating Centre for TB/HIV and TB Elimination, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
| |
Collapse
|
2
|
Rojek AM, Gkolfinopoulou K, Veizis A, Lambrou A, Castle L, Georgakopoulou T, Blanchet K, Panagiotopoulos T, Horby PW. Clinical assessment is a neglected component of outbreak preparedness: evidence from refugee camps in Greece. BMC Med 2018; 16:43. [PMID: 29551092 PMCID: PMC5858141 DOI: 10.1186/s12916-018-1015-9] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/14/2017] [Accepted: 01/29/2018] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND Refugees may have an increased vulnerability to infectious diseases, and the consequences of an outbreak are more severe in a refugee camp. When an outbreak is suspected, access to clinical information is critical for investigators to verify that an outbreak is occurring, to determine the cause and to select interventions to control it. Experience from previous outbreaks suggests that the accuracy and completeness of this information is poor. This study is the first to assess the adequacy of clinical characterisation of acute medical illnesses in refugee camps. The objective is to direct improvements in outbreak identification and management in this vulnerable setting. METHODS We collected prospective data in 13 refugee camps in Greece. We passively observed consultations where patients presented with syndromes that might warrant inclusion into an existing syndromic surveillance system and then undertook a structured assessment of routine clinical data collection to examine the extent to which key clinical parameters required for an outbreak response were ascertained and then documented. RESULTS A total of 528 patient consultations were included. The most common presenting condition was an acute respiratory illness. Clinicians often made a comprehensive clinical assessment, especially for common syndromes of respiratory and gastrointestinal conditions, but documented their findings less frequently. For fewer than 5% of patients were a full set of vital signs ascertained and so the severity of patient illnesses was largely unknown. In only 11% of consultations was it verified that a patient who met the case criteria for syndromic surveillance reporting based on an independent assessment was reported into the system. DISCUSSION Opportunities exist to strengthen clinical data capture and recording in refugee camps, which will produce a better calibrated and directed public health response. CONCLUSION Information of significant utility for outbreak response is collected at the clinical interface and we recommend improving how this information is recorded and linked into surveillance systems.
Collapse
Affiliation(s)
- Amanda M Rojek
- Epidemic Diseases Research Group, University of Oxford, Wellcome Trust Centre for Human Genetics, Oxford, UK.
| | | | | | - Angeliki Lambrou
- Hellenic Centre for Disease Prevention and Control (KEELPNO), Agrafon 3-5, Athens, Greece
| | - Lyndsey Castle
- Epidemic Diseases Research Group, University of Oxford, Wellcome Trust Centre for Human Genetics, Oxford, UK
| | - Theano Georgakopoulou
- Hellenic Centre for Disease Prevention and Control (KEELPNO), Agrafon 3-5, Athens, Greece
| | - Karl Blanchet
- Health in Humanitarian Crises Centre, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK
| | | | - Peter W Horby
- Epidemic Diseases Research Group, University of Oxford, Wellcome Trust Centre for Human Genetics, Oxford, UK
| | | |
Collapse
|